Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00986700
Other study ID # SHEBA-09-7156-JI-CTIL
Secondary ID
Status Completed
Phase N/A
First received September 29, 2009
Last updated June 18, 2017
Start date October 2009
Est. completion date September 2016

Study information

Verified date June 2017
Source Sheba Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

High fasting glucose is a very common problem in type 2 diabetic patients. The cause is probably glucose production by the liver, known as the "dawn phenomenon". The investigators hypothesize that a late night meal can lower the fasting glucose level by early morning insulin secretion stimulated by the food. In this study the investigators intend to test the effect of different kinds of late night meals on fasting glucose in type 2 diabetic patients.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender All
Age group 30 Years and older
Eligibility Inclusion Criteria:

- Type 2 diabetes mellitus with HbA1c 6.5-9%, fasting glucose of 126-200 mg/dl and BMI of 27-40.

Exclusion Criteria:

- Patient treated with insulin, GLP-1 analog or weight reduction medications.

- Type 1 diabetes

- Pregnancy

- Renal failure (creatinin >1.4 for male and 1.3 for female

- Uncontrolled hypertension (>160/100)

- Abnormal thyroid function test

- Patient treated with steroids or psychiatric medications.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
late night meal
Three different kinds of late night meal each for 2 days.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sheba Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary fasting glucose level 2 weeks